CD8A and cancer: IL-2 promotes the expansion and activation of NK cells, CD4+, and CD8+ T cells, while IL-15 activates DCs, stimulates the proliferation of T cells, and enhances the development of NK cells, cells which are all involved in the cancer immuno-surveillance [69].